|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Heart, Lung, and Blood Institute (NHLBI) |
|---|---|
| Collaborator: |
Blood and Marrow Transplant Clinical Trials Network |
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00023530 |
Purpose
The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.
| Condition | Intervention |
|---|---|
|
Bone Marrow Transplantation Blood Disease Hematopoietic Stem Cell Transplantation Leukemia Multiple Myeloma Myelodysplastic Syndromes Graft vs Host Disease |
Drug: fluconazole Drug: voriconazole Procedure: bone marrow transplant Drug: thalidomide Drug: dexamethasone |
| Study Type: | Interventional |
| Study Design: | Prevention, Randomized, Double-Blind, Placebo Control |
| Official Title: | Blood and Marrow Transplant Clinical Research Network |
Eligibility| Ages Eligible for Study: | 2 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria for entry into a study varies by protocol
Contacts and Locations| United States, California | |
| University of California at San Diego | |
| La Jolla, California, United States, 92093 | |
| City of Hope National Medical Center | |
| Duarte, California, United States, 91010 | |
| Stanford University | |
| Palo Alto, California, United States, 94305 | |
| United States, Florida | |
| University of Florida | |
| Gainesville, Florida, United States, 32610 | |
| United States, Maryland | |
| Johns Hopkins University | |
| Baltimore, Maryland, United States, 21231 | |
| United States, Massachusetts | |
| Dana-Farber Cancer Institute | |
| Boston, Massachusetts, United States, 02115 | |
| United States, Michigan | |
| University of Michigan at Ann Arbor | |
| Ann Arbor, Michigan, United States, 48109 | |
| United States, Minnesota | |
| University of Minnesota Twin Cities | |
| Minneapolis, Minnesota, United States, 55455 | |
| United States, Missouri | |
| Children's Mercy Hospital | |
| Kansas City, Missouri, United States, 64108 | |
| United States, Nebraska | |
| University of Nebraska Medical Center | |
| Omaha, Nebraska, United States, 68198 | |
| United States, New York | |
| Sloan-Kettering Institute for Cancer Research | |
| New York, New York, United States, 10021 | |
| United States, North Carolina | |
| Duke University | |
| Durham, North Carolina, United States, 27705 | |
| United States, Ohio | |
| Case Western Reserve University | |
| Cleveland, Ohio, United States, 44106 | |
| United States, Pennsylvania | |
| University of Pennsylvania | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| United States, Texas | |
| MD Anderson Cancer Center | |
| Houston, Texas, United States, 77030 | |
| United States, Washington | |
| Fred Hutchinson Cancer Research Center | |
| Seattle, Washington, United States, 98109 | |
| Investigator: | Joseph Antin | Dana-Farber Cancer Institute |
| Investigator: | Frederick Appelbaum | Fred Hutchinson Cancer Research Center |
| Investigator: | Edward Ball | University of California, San Diego |
| Investigator: | James Ferrara | University of Michigan at Ann Arbor |
| Investigator: | Stephen Forman | City of Hope National Medical Center |
| Investigator: | Alan Gamis | Children's Mercy Hospital |
| Investigator: | Sergio Giralt | M.D. Anderson Cancer Center |
| Investigator: | Mary Horowitz | Medical College of Wisconsin |
| Investigator: | Richard Jones | Johns Hopkins University |
| Investigator: | Joanne Kurtzberg | Duke University |
| Investigator: | Gina Laport | Stanford University |
| Investigator: | Hillard Lazarus | Case Western Reserve University |
| Investigator: | Richard O'Reilly | Sloan-Kettering Institute for Cancer Research |
| Investigator: | Edward Stadtmauer | University of Pennsylvania |
| Investigator: | Julie Vose | University of Nebraska |
| Investigator: | Daniel Weisdorf | University of Minnesota |
| Investigator: | John Wingard | University of Florida |
More Information
| Study ID Numbers: | 139 |
| Study First Received: | September 7, 2001 |
| Last Updated: | November 29, 2007 |
| ClinicalTrials.gov Identifier: | NCT00023530 History of Changes |
| Health Authority: | United States: Federal Government |
|
Dexamethasone Anti-Inflammatory Agents Anti-Infective Agents Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Antiemetics Hormones Preleukemia Pathologic Processes Hemorrhagic Disorders Therapeutic Uses Voriconazole Cardiovascular Diseases Angiogenesis Modulating Agents Fluconazole |
Immunoproliferative Disorders Immune System Diseases Antineoplastic Agents, Hormonal Hematologic Diseases Glucocorticoids Multiple Myeloma Neoplasms Leprostatic Agents Precancerous Conditions Thalidomide Immunologic Factors Blood Protein Disorders Antineoplastic Agents Paraproteinemias Hemostatic Disorders |
